Clinical Trials Browser

Phase 3 × Completed × Crohn Disease × Clear all

NCT02499783 2019-01-04

Study to Evaluate the Safety and Efficacy of Adalimumab in Chinese Subjects With Moderate to Severe Crohn's Disease

Phase 3 Completed

205 enrolled 39 charts

Crohn Disease

NCT00552058 2018-08-09

Study to Evaluate Efficacy and Safety of Certolizumab Pegol for Induction of Remission in Patients With Crohn's Disease

Phase 3 Completed

439 enrolled 25 charts

Crohn Disease

NCT00333788 2018-08-07

Welcome2

Phase 3 Completed

233 enrolled 31 charts

Crohn Disease

NCT01369329 2016-12-07

A Study to Evaluate the Safety and Efficacy of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease Who Have Failed or Are Intolerant to Tumor Necrosis Factor (TNF) Antagonist Therapy (UNITI-1)

Phase 3 Completed

769 enrolled 13 charts

Colitis, Crohn Disease, Inflammatory Bowel Diseases

NCT00004941 2015-03-25

Phase III Randomized Study of Anti-Tumor Necrosis Factor Chimeric Monoclonal Antibody (cA2) for Patients With Enterocutaneous Fistulae as a Complication of Crohn's Disease

Phase 3 Completed

Gastrointestinal

Crohn Disease, Gastrointestinal Diseases, Rare Diseases

NCT00297648 2011-08-31

MUSIC

Phase 3 Completed

89 enrolled 43 charts

Crohn Disease

NCT00467922 2009-10-21

An Assessment of Goal-Directed Intraoperative Fluid Management in Hand Assisted Laparoscopic Colectomy

Phase 3 Completed

Gastrointestinal

Colitis, Ulcerative, Colonic Neoplasms, Colonic Polyps, Crohn Disease, Diverticulitis, Rectal Neoplasms